• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.69% Nasdaq Up2.12%

    Del Mar Pharmaceuticals Inc. (DMPI)

    -Other OTC
    0.85 0.06(7.59%) Dec 17, 2:53PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Del Mar Pharmaceuticals Inc.
    999 West Broadway
    Suite 720
    Vancouver, BC V5Z 1K5
    Canada - Map
    Phone: 604-629-5989
    Website: http://www.delmarpharma.com

    Index Membership:N/A
    Full Time Employees:4

    Business Summary 

    DelMar Pharmaceuticals, Inc. focuses on the discovery and development of medicines with the potential to treat cancer patients who have failed modern targeted or biologic therapy. Its principal product candidate includes VAL-083, a small-molecule chemotherapeutic agent, which is in Phase I/II study to evaluate the safety, tolerability, pharmacokinetics, and anti-cancer activity in patients with glioblastoma multiforme, a form of brain cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical Company for the manufacture and sale of VAL-083 in China. DelMar Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Vancouver, Canada.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Del Mar Pharmaceuticals Inc.

    Key Executives 
    Mr. Jeffrey A. Bacha B.Sc., M.B.A., 46
    Co-Founder, Chairman, Chief Exec. Officer, Pres and Member of Steering Committee
    Dr. Dennis M. Brown B.Sc., M.A., Ph.D., 65
    Co-Founder, Chief Scientific Officer, Director and Member of Steering Committee
    Dr. William J. Garner M.D., MPH, 48
    Co-Founder and Director
    Mr. Scott Praill , 47
    Chief Financial Officer and Principal Accounting Officer
    Dr. Victor Levin M.D.,
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders